This research successfully profiled the metabolites of Seagrass Enhalus acoroides through both in silico and in vitro studies, revealing its ability to combat breast cancer by inhibiting HIF-1α, EGFR tyrosine kinase, and HER2 through molecular docking. Here, ERBB2 is linked to breast carcinoma.